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Purpose: The aim of this study was to explore the usefulness of the resistive index (RI) on spectral 
Doppler ultrasonography (US) in the detection of renal cell carcinoma (RCC) in patients with end-
stage renal disease (ESRD).
Methods: Seventeen ESRD patients with kidneys in which renal masses were suspected in 
routine US were subjected. They underwent computed tomography scans and additional Doppler 
US for the characterization of the detected lesions. All underwent radical nephrectomy with the 
suspicion of RCC. Fourteen patients finally were included. RI measurements were conducted in 
the region of the suspected renal mass and the background renal parenchyma. The intraclass 
correlation coefficient was used to assess the reproducibility of the RI measurement. A paired 
t-test was used to compare the RI values between the renal mass and the background renal 
parenchyma (P<0.05).
Results: The RI values measured at the RCCs were significantly lower than those measured 
at the background renal parenchyma (0.41-0.65 vs. 0.75-0.89; P<0.001). The intrareader 
reproducibility proved to be excellent and good for the renal masses and the parenchyma, 
respectively (P<0.001).
Conclusion: RI on spectral Doppler US is useful in detecting RCC in patients with ESRD. The RI 
values measured at the RCCs were significantly lower than those measured at the background 
renal parenchyma.
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Introduction
Incidence of renal cell carcinoma (RCC) in patients with end-stage 
renal disease (ESRD) is higher than that in the general population 
[1,2]. In general, ultrasonography (US) is the most widely used 
screening tool for RCC in patients with ESRD. In the case of a 
suspicion of a renal mass in an ESRD kidney upon US, a further 
examination using contrast enhanced computed tomography (CECT) 
or magnetic resonance imaging (MRI) may be necessary to clarify 
the detected lesion.
As the ESRD kidney shows heterogeneous and hyperechoic 
parenchymal echo-texture and irregular parenchymal contour 
associated with uneven parenchymal atrophy and compensatory 
hypertrophy, it may be more difficult to detect RCC in ESRD kidneys 
using US than in non-ESRD kidneys. A compensatory hypertrophy 
may sometimes produce a mass effect or compress the pelvo-
calyceal systems and thus closely mimic renal neoplasm [3]. It is 
important not only to be able to detect a renal mass in the ESRD 
kidney but also to be aware of the tumor mimicking compensatory 
hypertrophy so as to avoid unnecessary surgical procedures to 
preserve what is remaining of the functioning parenchyma. 
Previously, investigators have assessed the value of CECT and 
diffusion-weighted image (DWI) for detecting RCC in ESRD kidneys 
[4,5]. Despite the excellent results, there are some concerns 
regarding the use of CECT because iodinated contrast agents have 
the risk of contrast-induced nephropathy. Furthermore, although 
DWI does not have the risks caused by ionizing radiation or contrast 
agents, it is limited in terms of accessibility.
Among the several diagnostic parameters of US, the resistive 
index (RI) can be used in the detection of RCC in ESRD kidneys. 
RI values tend to increase in proportion to the progression of 
glomerular sclerosis, tubulointerstitial changes and arteriosclerosis 
in ESRD kidneys. In contrast, the neovascularized arterial wall of 
a malignant tumor such as RCC is known to be deficient in the 
muscular medial layer which results in an increase of the diastolic 
flow and correspondingly lower RI values [6,7]. Considering the 
relatively high RI of the background parenchyma of ESRD kidneys, 
we speculated that the RI measured in the intra-tumoral artery of 
RCC would be lower than that of the background renal parenchyma. 
This study was undertaken to assess the usefulness of the RI on 
spectral Doppler US in the detection of RCC in patients with ESRD.
Materials and Methods
Patient Selection
Our institutional review board approved this retrospective study and 
waived the requirement for informed consent. From February 2007 
to September 2013, we identified 17 ESRD patients with kidneys in 
which renal masses were suspected in routine US. They underwent 
computed tomography (CT) scans and additional renal Doppler 
US for the characterization of the detected masses. All underwent 
radical nephrectomy with the suspicion of RCC in CT scans and 
additional renal Doppler US. Three of these patients were excluded 
from this study because their RI values could not be measured due 
to excessively small sizes or a lack of vascularity of the renal mass 
and background renal parenchyma, or because acquiring spectral 
Doppler US was difficult due to a lack of respiratory cooperation. 
This study was a retrospective evaluation of the collected data, 
and all clinical information including patient demographics and 
histopathological findings was reviewed by one author (SYK).
US Examination and Measurement of RI
Real-time US devices with color Doppler capacity (Aplio XG, Toshiba, 
Japan; iU22 Xmatrix, Philips, Netherland) and 3-5-MHz convex 
transducers were used. Renal US procedures including color and 
spectral Doppler were performed by a genitourinary radiologist (JYC 
with 17 years of experience). 
For stable image acquisition, all patients were set in the decubitus 
position with an upward location of the involved kidney and rested 
for 5 minutes prior to the procedure. All patients underwent gray 
scaled, color and spectral Doppler US, successively. All images were 
acquired when the patients held their breath after inspiration. 
After observation of the intrarenal arteries by color Doppler US, the 
spectral Doppler waveforms were obtained from the intratumoral 
arteries (those of the renal masses) and from segmental arteries 
(those of the renal parenchyma) with the inspection of three 
continuous Doppler waveforms. The Doppler sample volume was set 
at 5 mm, and the Doppler scale was maximized by using the smallest 
possible frequency range (minimum pulse repetition frequency) that 
did not produce aliasing. The wall filter was set to low in order to 
detect low velocity. The penetration mode (lower megahertz, MHz) 
was also used in order to correct the poor vascularity on the ESRD 
kidney.
RI was calculated as (peak systolic velocity - end-diastolic 
velocity) / peak-systolic velocity. The RI of the suspected renal mass 
lesion on the gray scaled US or previous CT scans was measured 
twice and that of the renal parenchyma was measured three times. 
The mean RI values of the mass and the renal parenchyma were 
calculated and analyzed.
Histopathological analyses
All patients underwent radical nephrectomy under the impression 
of RCC in the ESRD kidney. The histopathological analyses were 
performed by the genitourinary pathologist.Sang Youn Kim, et al.
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Statistical analysis
A paired t-test was used to compare the RI values between the 
renal mass and the background renal parenchyma. The intraclass 
correlation coefficient (ICC) was used to assess the reproducibility 
of the RI measurements. All statistical analyses were performed with 
Medcalc (ver. 12.0, Medcalc Software, Mariakerke, Belgium). A two-
tailed P-value of <0.05 was considered to indicate a statistically 
significant difference.
Results
Characteristics of Patients and Renal Lesions
The characteristics of the patients and focal renal lesions are 
described in Table 1. In all, 14 patients (12 men and 2 women; mean 
age, 58.6±13.5 years; age range, 31 to 85 years) were included in 
our study.
Fourteen patients had RCC (mean size, 1.73±0.80 cm; range, 
0.90 to 2.50 cm). The histopathological subtypes included the clear 
cell (n=8), papillary (n=2), chromophobe (n=1), acquired cystic 
kidney disease-associated (n=2), and unclassified (n=1) types. The 
underlying causes of ESRD were as follows: glomerulonephropathy 
(n=4), hypertension (n=4), diabetes mellitus (n=3), autosomal 
dominant polycystic kidney disease (ADPKD) (n=1), and unknown 
(n=2). The mean serum creatinine level was 7.09±4.42 mg/dL (range, 
1.16 to 14.59 mg/dL). The mean estimated glomerular filtration 
rate (GFR) level was 16.19±17.50 mL/mg/1.73 m
2 (range, 3.4 to 
63.4 mL/mg/1.73 m
2). Eight patients showed acquired cystic renal 
disease. Nine patients underwent dialysis. The mean period of the 
dialysis was 3.49±5.80 years (range, 0 to 20.0 years).
Gray Scaled and Color Doppler US Findings of the Renal 
Masses
Among the 14 RCC lesions, 10 lesions showed mainly solid features 
and 4 lesions showed complex cystic (solid and cystic) features 
in the gray scaled US. The echogenicity of the mass in the gray 
scaled US was as follows: hyperechoic (n=3), isoechoic (n=7), and 
hypoechoic (n=4). Most of the RCCs (n=10) showed increased 
intra-tumoral vascularity with peripherally hypervascular patterns, 
although the ESRD kidneys showed decreased vascularity.
RI of the Renal Masses and Background Renal Parenchyma
The RI of the renal masses and background renal parenchyma are 
shown in Fig. 1. In patients with RCC, the mean RI of the RCCs was 
0.56±0.06 (range, 0.41 to 0.65). The mean RI of the background 
renal parenchyma was 0.81±0.04 (range, 0.75 to 0.89). The RI 
values measured at RCCs were significantly lower than those 
measured at the background renal parenchyma (0.41-0.65 vs. 
0.75-0.89; P<0.001). Since there was no overlap between the RI 
values in the RCCs and the renal parenchyma, it is possible to assign 
cut-off values in the range of 0.65-0.75 for the discrimination of 
Table 1. Characteristics of patients and renal cell carcinomas
Patient 
no.
Age 
(yr) Sex Pathologic 
subtype
Fuhrman 
nuclear 
grade
Size 
(cm)
Underlying 
cause of 
ESRD
ACDS Dialysis
Period of 
dialysis 
(yr)
Serum Cr 
(mg/dL)
Estimated GFR 
(mL/min/
1.73 m
2)
Transplantation 
of kidney
1 31 F Papillary III/IV 1.3 FSGS Yes PD 6.0 6.9 9.0 No
2 64 M Clear cell II/IV 1.5 Unknown Yes No 0 2.3 28.0 Yes
3 65 M Chromophobe II/IV 1.4 GN Yes No 0 1.16 63.4 Yes
4 59 M Unclassified IV/IV 2.0 GN Yes PD 10.0 14.4 3.4 No
5 44 M Clear cell I/IV 1.0 Hypertension Yes PD 8.0 9.31 6.2 No
6 60 M ACD-RCC III/IV 2.5 ADPKD No PD 0.5 8.1 6.9 No
7 77 F Clear cell II/IV 0.9 GN Yes HD 20.0 5.2 9.0 No
8 62 M Clear cell II/IV 1.5 Hypertension No HD 2.5 7.89 7.0 No
9 61 M Clear cell III/IV 3.0 DM Yes HD 0.5 2.08 32.6 Yes
10 85 M Papillary III/IV 3.0 DM No PD 0.3 1.7 36.0 No
11 56 M Clear cell III/IV 1.0 Hypertension No No 0 14.59 3.5 Yes
12 61 M Clear cell II/IV 2.9 Hypertension No HD 1.0 8.1 6.8 No
13 51 M Clear cell II/IV 1.2 DM Yes No 0 5.99 10 No
14 44 M ACD-RCC I/IV 1.0 Unknown No No 0 11.48 4.9 No
ESDR, end-stage renal disease; ACDS, acquired cystic renal disease; GFR, glomerular filtration rate; FSGS, focal segmental glomerulosclerosis; PD, peritoneal dialysis; GN, 
glomerulonephritis; ACD-RCC, acquired cystic disease associated renal cell carcinoma; ADPKD, autosomal dominant polycystic kidney disease; HD, hemodialysis; DM, diabetes 
mellitus.  Usefulness of RI in the detection of RCC in ESRD kidney
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the RCCs from the background renal parenchyma (Fig. 2). 
Reproducibility of RI Values
For the 14 renal mass lesions, the RI values showed excellent 
reproducibility with ICC of 0.96 (P<0.001). The RI values of the 
background parenchyma also demonstrated good reproducibility 
with ICC of 0.80 (P<0.001).
Discussion
It is well known that the incidence of malignancy in patients with 
ESRD is higher than that in the general population, possibly due to 
their immunosuppressed condition [8]. The most common malignant 
neoplasm is RCC. In general, RCC in patients with ESRD is known 
to grow at a rate of approximately 0.5-1.0 cm yearly [1,9]. Ninety 
percent of patients treated with dialysis for more than 10 years 
develop acquired cystic renal disease, and the risk of RCC increases 
considerably in patients undergoing dialysis for more than 10 years. 
Gulanikar et al. [10] reported that the sensitivity of screening US in 
ESRD patients was good and that the positive predictive value of a 
solid mass was 100%. Screening CT is more sensitive than US but 
CT is not as cost-effective as US. Repeated follow-up imaging to 
screen for RCC including US is important in ESRD patients [2].
However, it is difficult to detect RCC in an ESRD kidney using the 
conventional gray scaled or color Doppler US because the ESRD 
kidney shows a heterogeneous hyperechoic parenchymal echo-
texture and diffuse parenchymal thinning with uneven thickness. 
Furthermore, long-term dialysis in patients with ESRD almost 
invariably results in acquired renal cystic disease in ESRD kidneys. The 
numerous acquired cysts that develop may interrupt the appropriate 
imaging acquisition for the diagnosis of renal neoplasm in ESRD 
kidneys. Sometimes, segmental or regional sparing and subsequent 
hypertrophy in non-uniform parenchymal atrophy known as 
compensatory hypertrophy can mimic renal tumorous conditions [3].
Previously, there have been efforts to detect RCC in patients 
with ESRD kidneys using several modalities. Among them, early 
CECT and DWI have shown promising results. Takebayashi et 
al. [4] demonstrated that early enhanced helical CT was able to 
detect more RCCs than delayed enhanced helical CT in ESRD 
patients with and without acquired cystic kidney disease because 
the cortex of the ESRD kidneys shows minimal enhancement in 
the early phase, rendering higher differences in the attenuation 
values between the RCC and the atrophic parenchyma. However, 
as ESRD patients require life-long follow-up, screening with CECT 
may be burdensome in that it uses ionizing radiation and poses a 
risk for contrast-induced nephropathy. Goyal et al. [5] reported that 
DWI could successfully differentiate between RCCs and pseudo-
tumors. However, as all but one of the cases of RCCs in their 
study did not have ESRD, the true value of DWI in differentiating 
RCCs and pseudo-tumors in ESRD patients remains in question. 
Moreover, although MRI is increasingly being used for the detection 
and characterization of renal masses, it is still limited in terms of 
accessibility compared with CT or US.
In our study, we found that RCCs arising in ESRD kidneys 
showed significantly lower RI values than the background renal 
parenchyma. There was no overlap at all in the measured RI values 
between the two. Glomerulosclerosis, tubulointerstitial damage and 
vascular lesions have been reported to correlate with an increase 
of RI. In chronic renal disease, an RI value of more than 0.70 is 
an independent risk factor for worsening renal function [11-13]. 
RI is thought to be a complex integration of arterial compliance, 
pulsatility and peripheral resistance. RI correlates well with renal 
arteriolosclerosis, indicating that RI can reflect renal vascular 
resistance. On the other hand, RI correlates with extrarenal markers 
of vascular stiffness, such as the intima-medial thickness of the 
femoral and carotid arteries [13-15].
In an angiographic study, 92% of the RCCs demonstrated tumor 
neovascularity. Histopathologically, neovascularized vessels are 
primitive, avascular channels that lack smooth muscle and often 
consist of an endothelial layer and connective tissue alone [6]. 
Since the neovascularized arterial walls of malignant tumors such 
as RCCs lack normal arteriolar smooth muscle, particularly the 
Fig. 1. The resistive index (RI) of the renal masses and the 
background renal parenchyma. In patients with renal cell 
carcinoma (RCC), the mean RI of the RCCs is 0.56±0.06 (range, 
0.41 to 0.65). The mean RI of the background renal parenchyma is 
0.81±0.04 (range, 0.75 to 0.89). The RI values measured at RCCs 
are significantly lower than those measured at the background 
renal parenchyma (0.41-0.65 vs. 0.75-0.89; P<0.001). There is no 
overlap between the RI values in the RCCs and renal parenchyma. In 
contrast with patients with RCC, the pseudo-tumor shows a higher 
RI value (0.92) than the renal parenchyma (0.86).
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muscular medial layer, low resistance to flow in such vessels can 
be expected. The lack or paucity of the medial layer results in an 
increase of the diastolic flow of the tumor vessel. The RI measured 
from a neovascularized intra-tumoral artery is expected to be lower 
than that from the adjacent parenchymal artery. As the RI of the 
renal parenchyma of an ESRD kidney is high (more than 0.70), the 
increase of diastolic flow (and decrease of RI) in a suspected renal 
mass in an ESRD kidney is suggestive of RCC [6,7].
There was one patient with histopathologically proven com-
pensatory hypertrophy that manifested as a pseudo-tumor in US. 
The mean RI value was 0.92 and that of the background renal 
parenchyma was 0.86. Because there was only one such case, 
we could not draw a statistically meaningful strong conclusion 
regarding the value of RI in differentiating between RCCs and 
pseudo-tumors in patients with underlying ESRD. However, we 
believe that this preliminary comparison brings insight and interest 
for further investigation. Compensatory hypertrophy consists of focal 
tissue hypertrophy of the relatively preserved renal parenchyma in 
chronic kidney disease, but unlike RCC, it does not contain vessels 
that lack the normal arteriolar smooth muscle. Therefore, we may 
A B
Fig. 2. A 62-year-old patient with a transplanted kidney. 
A. On gray scale ultrasonography, an exophytic low echoic lesion (annotated as "A") is observed in the right native kidney with a peripherally 
hypervascular feature (RK, right kidney). B. The resistive index (RI) value of the lesion is 0.63. The mean RI value of the lesion is 0.65. C. The 
RI value of the renal parenchyma is 0.82. The mean RI value of the lesion is 0.85. D. In the corticomedullary phased computed tomography 
images, the lesion shows early heterogeneous enhancement (arrows). After radical nephrectomy, this lesion was confirmed as clear cell renal 
cell carcinoma in the end-stage renal disease kidney. 
C DUsefulness of RI in the detection of RCC in ESRD kidney
e-ultrasonography.org  Ultrasonography 33(2), April 2014 141
Hyup Kim: http://orcid.org/0000-0002-9339-5907
Conflict of Interest
No potential conflict of interest relevant to this article was reported.
Acknowledgments
This study was supported in part by the Research Fund of the Korean 
Society of Ultrasound in Medicine.
References
 1.  Farivar-Mohseni H, Perlmutter AE, Wilson S, Shingleton WB, Bigler 
SA, Fowler JE Jr. Renal cell carcinoma and end stage renal disease. 
J Urol 2006;175:2018-2020.
  2.  Kojima Y, Takahara S, Miyake O, Nonomura N, Morimoto A, Mori H. 
Renal cell carcinoma in dialysis patients: a single center experience. 
Int J Urol 2006;13:1045-1048.
 3. Cho C, Friedland GW, Swenson RS. Acquired renal cystic disease 
and renal neoplasms in hemodialysis patients. Urol Radiol 
1984;6:153-157.
 4. Takebayashi S, Hidai H, Chiba T, Takagi H, Koike S, Matsubara 
S. Using helical CT to evaluate renal cell carcinoma in patients 
undergoing hemodialysis: value of early enhanced images. AJR Am 
J Roentgenol 1999;172:429-433.
 5. Goyal A, Sharma R, Bhalla AS, Gamanagatti S, Seth A. 
Pseudotumours in chronic kidney disease: can diffusion-weighted 
MRI rule out malignancy. Eur J Radiol 2013;82:1870-1876.
 6. Taylor KJ, Ramos I, Carter D, Morse SS, Snower D, Fortune K. 
Correlation of Doppler US tumor signals with neovascular 
morphologic features. Radiology 1988;166:57-62. 
 7.  Fleischer AC, Rodgers WH, Kepple DM, Williams LL, Jones HW 3rd, 
Gross PR. Color Doppler sonography of benign and malignant 
ovarian masses. Radiographics 1992;12:879-885.
 8. Kjellstrand CM. Are malignancies increased in uremia? Nephron 
1979;23:159-161.
 9. Heinz-Peer G, Schoder M, Rand T, Mayer G, Mostbeck GH. 
Prevalence of acquired cystic kidney disease and tumors in native 
kidneys of renal transplant recipients: a prospective US study. 
Radiology 1995;195:667-671. 
10.  Gulanikar AC, Daily PP, Kilambi NK, Hamrick-Turner JE, Butkus DE. 
Prospective pretransplant ultrasound screening in 206 patients 
for acquired renal cysts and renal cell carcinoma. Transplantation 
1998;66:1669-1672.
11. Mostbeck GH, Kain R, Mallek R, Derfler K, Walter R, Havelec L, 
et al. Duplex Doppler sonography in renal parenchymal disease: 
histopathologic correlation. J Ultrasound Med 1991;10:189-194.
12.  Boddi M, Cecioni I, Poggesi L, Fiorentino F, Olianti K, Berardino S, 
et al. Renal resistive index early detects chronic tubulointerstitial 
nephropathy in normo- and hypertensive patients. Am J Nephrol 
speculate that in comparison with RCC, compensatory hypertrophy 
may not demonstrate significantly decreased RI compared to the 
background ESRD kidney. Due to our limitation of a small number of 
cases with compensatory hypertrophy, further investigation with a 
larger study population is warranted to confirm our speculation.
With respect to the use of RI, we expect that concerns such as the 
following could be raised: (1) reproducibility in measuring RI and (2) 
the possibility that RI may be affected by other extrinsic factors. First, 
although we did not perform an interreader reproducibility study, we 
performed repeated measurements for both the renal masses and 
the background renal parenchyma. We used the mean value as the 
representative RI value for each entity and performed an intrareader 
reproducibility study as well. The intrareader reproducibility using 
ICC within subjects proved to be excellent and good for the renal 
masses and the parenchyma, respectively. Second, RI is well known 
to be affected by various factors such as kidney compression, breath 
holding during the Valsalva maneuver, extreme bradycardia and 
extrarenal markers of vascular stiffness [16]. However, we propose 
that the presence of a significant difference in RI between RCCs and 
the background parenchyma may be useful. This is more likely to be 
less dependent on the effect of external variables.
Our study has several limitations. First, the sample size was 
relatively small considering the long study period. Still, we were able 
to demonstrate a significant difference in RI values between RCCs 
and the background renal parenchyma of ESRD kidneys. Second, we 
had only one case of compensatory hypertrophy that manifested as 
a pseudo-tumor. Although this case of compensatory hypertrophy, 
unlike the RCC case, showed a high RI value as the background 
renal parenchyma of the ESRD kidney, we recognize that it is 
premature to derive a strong conclusion regarding the discrimination 
between RCCs and compensatory hypertrophy from our study 
results. Third, we did not perform an interreader reproducibility 
study. US itself is a highly operator-dependent modality. Moreover, it 
may be even more difficult to measure RI in ESRD kidneys, which are 
commonly atrophied and decreased in internal perfusion. A further 
problem is posed when the suspicious renal mass is small.
Despite its limitations, the RI on spectral Doppler US is useful 
in detecting RCC in patients with ESRD. The RI values measured 
at RCCs were significantly lower than those measured at the 
background parenchyma. Further studies are warranted to assess its 
value for differentiation between RCCs and pseudo-tumors.
ORCID: Sang Youn Kim: http://orcid.org/0000-0003-4038-7345; Sungmin Woo: 
http://orcid.org/0000-0001-8459-8369; Sung Il Hwang: http://orcid.org/0000-0001-
7516-5369; Min Hoan Moon: http://orcid.org/0000-0003-2448-2895; Chang Kyu 
Sung: http://orcid.org/0000-0003-4922-5107; Hak Jong Lee: http://orcid.org/0000-
0003-0858-7873; Jeong Yeon Cho: http://orcid.org/0000-0001-8659-0918; Seung Sang Youn Kim, et al.
142   Ultrasonography 33(2), April 2014  e-ultrasonography.org
2006;26:16-21. 
13. Sugiura T, Wada A. Resistive index predicts renal prognosis in 
chronic kidney disease: results of a 4-year follow-up. Clin Exp 
Nephrol 2011;15:114-120. 
14.  Ikee R, Kobayashi S, Hemmi N, Imakiire T, Kikuchi Y, Moriya H, et al. 
Correlation between the resistive index by Doppler ultrasound and 
kidney function and histology. Am J Kidney Dis 2005;46:603-609.
15. Ishimura E, Nishizawa Y, Kawagishi T, Okuno Y, Kogawa K, 
Fukumoto S, et al. Intrarenal hemodynamic abnormalities in 
diabetic nephropathy measured by duplex Doppler sonography. 
Kidney Int 1997;51:1920-1927.
16. Radermacher J. Resistive index: an ideal test for renovascular 
disease or ischemic nephropathy? Nat Clin Pract Nephrol 2006;2: 
232-233.